Gabapentinoids: Difference between revisions

>Graham
m wiki ref formatting
>Blackhole
remove substance category
 
(16 intermediate revisions by 2 users not shown)
Line 1: Line 1:
{{Stub}}
[[File:GABA.svg|250px|thumbnail|Skeletal structure of the [[GABA|gamma-aminobutyric acid]] (GABA) molecule.]]
[[File:Gabapentinoidsstructure.png|250px|thumbnail|Diagram showing the structural similarities of [[GABA|gamma-aminobutyric acid]] (GABA), [[pregabalin]] and [[gabapentin]].]]


'''Gabapentinoids''', also known as α<sub>2</sub>δ ligands, are a relatively small chemical class of [[psychoactive substances]] derived from [[GABA|gamma-aminobutyric acid]] (GABA).{{citation needed}} Members of this class include [[gabapentin]], [[F-phenibut]], [[phenibut]] and [[pregabalin]].  
'''Gabapentinoids''', also known as α<sub>2</sub>δ ligands, are a relatively small chemical class of [[psychoactive substances]] derived from [[GABA|gamma-aminobutyric acid]] (GABA).{{citation needed}} Members of this class include [[gabapentin]], [[F-phenibut]], [[phenibut]] and [[pregabalin]].  
Line 12: Line 11:


Gabapentinoids closely resemble the α-amino acids <small>L</small>-leucine and <small>L</small>-isoleucine, and this may be of greater relevance in relation to their pharmacodynamics than their structural similarity to GABA.<ref name=":0">{{cite journal | vauthors=((Dooley, D. J.)), ((Taylor, C. P.)), ((Donevan, S.)), ((Feltner, D.)) | journal=Trends in Pharmacological Sciences | title=Ca2+ channel α2δ ligands: novel modulators of neurotransmission | volume=28 | issue=2 | pages=75–82 | date= February 2007 | url=https://linkinghub.elsevier.com/retrieve/pii/S0165614706002896 | issn=01656147 | doi=10.1016/j.tips.2006.12.006}}</ref>
Gabapentinoids closely resemble the α-amino acids <small>L</small>-leucine and <small>L</small>-isoleucine, and this may be of greater relevance in relation to their pharmacodynamics than their structural similarity to GABA.<ref name=":0">{{cite journal | vauthors=((Dooley, D. J.)), ((Taylor, C. P.)), ((Donevan, S.)), ((Feltner, D.)) | journal=Trends in Pharmacological Sciences | title=Ca2+ channel α2δ ligands: novel modulators of neurotransmission | volume=28 | issue=2 | pages=75–82 | date= February 2007 | url=https://linkinghub.elsevier.com/retrieve/pii/S0165614706002896 | issn=01656147 | doi=10.1016/j.tips.2006.12.006}}</ref>
==List of Gabapentinoids==
{| class="wikitable"
|-
! scope="col" |'''Compound'''
! scope="col" style="width: 50px;" |'''R<sub>3</sub>'''
! scope="col" |'''Structure'''
|-
|[[GABA]]||H||[[File:GABA.svg|200px]]
|-
|[[Pregabalin]]||CH<sub>2</sub>CH(CH<sub>3</sub>)<sub>2</sub>||[[File:Pregabalin.svg|200px]]
|-
|[[Gabapentin]]||C<sub>5</sub>H<sub>10</sub>||[[File:Gabapentin.svg|200px]]
|-
|[[Phenibut]]||C<sub>6</sub>H<sub>5</sub>||[[File:Phenibut.svg|200px]]
|-
|[[F-Phenibut]]||C<sub>6</sub>H<sub>4</sub>F||[[File:F-Phenibut.svg|200px]]
|-
|[[Baclofen]]||C<sub>6</sub>H<sub>4</sub>Cl||[[File:Baclofen.svg|200px]]
|}


==Pharmacology==
==Pharmacology==
Line 24: Line 43:


Gabapentin, pregabalin, and phenibut all undergo little or no metabolism. Conversely, gabapentin enacarbil, which acts as a prodrug of gabapentin, must undergo enzymatic hydrolysis to become active. This is done via non-specific esterases in the intestines and to a lesser extent in the liver.<ref name=":1" />
Gabapentin, pregabalin, and phenibut all undergo little or no metabolism. Conversely, gabapentin enacarbil, which acts as a prodrug of gabapentin, must undergo enzymatic hydrolysis to become active. This is done via non-specific esterases in the intestines and to a lesser extent in the liver.<ref name=":1" />
==Examples==
*[[F-Phenibut]]
*[[Gabapentin]]
*[[Phenibut]]
*[[Pregabalin]]
*[[Baclofen]]


==See also==
==See also==
Line 47: Line 58:
==References==
==References==


[[Category:Gabapentinoid| ]]
[[Category:Chemical class]]
[[Category:Chemical class]]
[[Category:Pharmacology]]
[[Category:Pharmacology]]
<references />
<references />